top of page
MARCH 15, 2022
RENATUS WAS SELECTED FOR THE HOSPITAL-BASED BUSINESS INNOVATION CENTER (HBIC) PROGRAM
Renatus was selected for Hospital-based Business Innovation Center (HBIC) program by Korea Health Industry Development Institute (KHIDI).
Renatus is a pharma company thriving to develop next generation cyclodextrins to provide safe treatment options for patients living with cholesterol-associated diseases. Renatus seeks to provide critical impact in developing translational cyclodextrin therapies and fulfill its vision to protect the world from various cholesterol-associate diseases. For more information, please visit www.renatustx.com
bottom of page